{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:44:59Z","timestamp":1792183499335,"version":"4.4.0"},"reference-count":75,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CA A Cancer J Clinicians"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer is the most common cancer among men in the United States, and the incidence of advanced disease is increasing rapidly. This article provides an overview of prostate cancer occurrence using population\u2010based incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Prostate cancer incidence trends have reversed from a decline of 6.4% per year during 2007 through 2014 to an increase of 3.0% annually during 2014 through 2021. The increasing trend is confined to distant\u2010stage disease in men younger than 55 years and to regional\/distant\u2010stage disease in men aged 55\u201369 years but includes early stage disease in men aged 70 years and older. Over the past decade of data, distant\u2010stage disease has increased by 2.6% annually in men younger than 55 years, 6.0% annually in men aged 55\u201369 years, and 6.2% annually in men aged 70 years and older. American Indian\/Alaska Native, Asian American\/Pacific Islander, and Hispanic men are less likely than Black and White men to be diagnosed with localized disease (64%\u201367% vs. 71%\u201372%). Compared with White men, American Indian\/Alaska Native men have 12% higher prostate cancer mortality despite 13% lower incidence, whereas Black men have double the prostate cancer mortality, with 67% higher incidence. In summary, continued increases in the diagnosis of advanced prostate cancer and persistent racial disparities underscore the need for redoubled efforts to optimize early detection while limiting overdiagnosis and to understand and address barriers to equitable outcomes.<\/jats:p>","DOI":"10.3322\/caac.70028","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:00:07Z","timestamp":1756821607000},"page":"485-497","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Prostate cancer statistics, 2025"],"prefix":"10.3322","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5618-6380","authenticated-orcid":false,"given":"Tyler B.","family":"Kratzer","sequence":"first","affiliation":[{"name":"Surveillance and Health Equity Science American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4168-5030","authenticated-orcid":false,"given":"Natalia","family":"Mazzitelli","sequence":"additional","affiliation":[{"name":"Surveillance and Health Equity Science American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3522-9609","authenticated-orcid":false,"given":"Jessica","family":"Star","sequence":"additional","affiliation":[{"name":"Surveillance and Health Equity Science American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2766-9703","authenticated-orcid":false,"given":"William L.","family":"Dahut","sequence":"additional","affiliation":[{"name":"Surveillance and Health Equity Science American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedin","family":"Jemal","sequence":"additional","affiliation":[{"name":"Surveillance and Health Equity Science American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-8522","authenticated-orcid":false,"given":"Rebecca L.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Surveillance and Health Equity Science American Cancer Society  Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588\u2010020\u201000748\u20100"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.13.981"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3712"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010149\u20103\u2010200808050\u201000008"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010157\u20102\u2010201207170\u201000459"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31549"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6695"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407934"},{"key":"e_1_2_6_11_1","volume-title":"SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data\u2014Cancer in North America Research Data, 1995\u20132019, with Race\/Ethnicity, Standard File, American Cancer Society Facts and Figures Projection Project, certified by the NAACCR as meeting high\u2010quality data standards for the specified time periods, submitted December 2021","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2022"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.20.1537"},{"key":"e_1_2_6_13_1","volume-title":"SEER*Stat Database: Incidence\u2014SEER Research Data with Delay Adjustment, 8 Registries, Malignant Only, November 2021 Submission (1975\u20132019)\u2014Linked To County Attributes\u2014Time Dependent (1990\u20132019) Income\/Rurality, 1969\u20132020 Counties, released April 2022","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2022"},{"key":"e_1_2_6_14_1","volume-title":"SEER*Stat Database: Incidence \u2010 SEER Research Limited\u2010Field Data, 21 Registries (excl IL), Nov 2024 Sub (2000\u20132022)","author":"Surveillance, Epidemiology, and End Results (SEER) Program"},{"key":"e_1_2_6_15_1","volume-title":"SEER*Stat Database: Mortality\u2014All Causes of Death, Aggregated With State, Total U.S. (1969\u20132020)","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2022"},{"issue":"12","key":"e_1_2_6_16_1","first-page":"1","article-title":"Mortality profile of the non\u2010Hispanic American Indian or Alaska Native population, 2019","volume":"70","author":"Arias E","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_6_17_1","volume-title":"Behavioral Risk Factor Surveillance System Survey Data","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21757"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.EPI\u201020\u20101727"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.EPI\u201020\u20101780"},{"key":"e_1_2_6_21_1","volume-title":"International Classification of Diseases for Oncology","author":"Fritz A","year":"2000"},{"key":"e_1_2_6_22_1","volume-title":"SEER*Stat software, version 8.4.0","author":"National Cancer Institute","year":"2022"},{"key":"e_1_2_6_23_1","volume-title":"Joinpoint Regression Program, version 4.9.1.0","author":"National Cancer Institute","year":"2022"},{"key":"e_1_2_6_24_1","volume-title":"DevCan: Probability of Developing or Dying of Cancer Software, version 6.8.0","author":"National Cancer Institute","year":"2022"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21335"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.Epi\u201009\u20100329"},{"key":"e_1_2_6_27_1","volume-title":"SEER*Stat Database: Incidence\u2014SEER Research Limited\u2010Field Data, 22 Registries (excluding Illinois and Massachusetts), November 2023 Submission (2000\u20132021)\u2014Linked To County Attributes\u2014Time Dependent (1990\u20132022) Income\/Rurality, 1969\u20132022 Counties, released April 2024, based on the November 2023 submission","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2024"},{"key":"e_1_2_6_28_1","volume-title":"SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data\u2014Cancer in North America Research Data, 1998\u20132021, Delay\u2010Adjusted Factors\u2014American Cancer Society Facts & Figures (which includes data from the Centers for Disease Control and Prevention's National Program of Cancer Registries, the Canadian Council of Cancer Registry's Provincial and Territorial Registries, and the National Cancer Institute's SEER Registries), certified by the NAACCR as meeting high\u2010quality incidence data standards for the specified time periods, submitted December 2023","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2023"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588\u2010023\u201001534\u20104"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.09.058"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/mou.0000000000000951"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.14905"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520310046028"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp001"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541\u20100420.2007.00825.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.5143"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21731"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214122"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26491"},{"key":"e_1_2_6_40_1","volume-title":"NCCN Guidelines\u00ae Version 2.2025: Prostate Cancer","author":"National Comprehensive Cancer Network (NCCN)","year":"2025"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.1439"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0228"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(23)00148\u20101"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(21)02437\u20105"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003998"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.Epi\u201024\u20101835"},{"key":"e_1_2_6_47_1","volume-title":"Cancer Facts & Figures for Asian American, Native Hawaiian, & Other Pacific Islander People 2024\u20132026","author":"American Cancer Society","year":"2024"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28683"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30687"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.19365"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.121.17570"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.025271"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.45906"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.03.007"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0826"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33224"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33643"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.37272"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18475"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50416"},{"key":"e_1_2_6_61_1","volume-title":"Area Socioeconomic Variations in US Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975\u20131999","author":"Singh GK","year":"2003"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/107497"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2819372"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf047"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.14582"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552\u2010007\u20109083\u20108"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2970"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2003.02.083"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199104253241702"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198710083171501"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.13.981"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3710"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20066"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad193"},{"key":"e_1_2_6_75_1","unstructured":"Centers for Medicare and Medicaid Services (CMS).Prostate Cancer Screening Tests. Accessed April 17 2025.https:\/\/www.cms.gov\/medicare\u2010coverage\u2010database\/view\/ncd.aspx?ncdid=268&ncdver=2&="},{"key":"e_1_2_6_76_1","volume-title":"Prostate Specific Antigen (PSA) Testing policy for reimbursement","author":"BlueCross BlueShield of Texas","year":"2024"}],"container-title":["CA: A Cancer Journal for Clinicians"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.3322\/caac.70028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:21:15Z","timestamp":1762514475000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.70028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.3322\/caac.70028"],"URL":"https:\/\/doi.org\/10.3322\/caac.70028","archive":["Portico"],"relation":{},"ISSN":["0007-9235","1542-4863"],"issn-type":[{"value":"0007-9235","type":"print"},{"value":"1542-4863","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"2025-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}